Somatic genetics empowers the mouse for modeling and interrogating developmental and disease processes

PLoS Genetics

Volumn 7, Issue 7, 2011, Pages

  Landrette, Sean F ^a   Xu, Tian ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; INTEGRASE; LENTIVIRUS VECTOR; RETROVIRUS VECTOR; SHORT HAIRPIN RNA; MUTAGENIC AGENT;

DISEASE COURSE; DISEASE MODEL; GENE INDUCTION; GENE INSERTION; GENE MAPPING; GENE OVEREXPRESSION; GENE SILENCING; GENE TARGETING; GENETIC ASSOCIATION; GENETIC MANIPULATION; GENETIC MODEL; GENETIC SCREENING; GERM LINE; HIGH THROUGHPUT SCREENING; HUMAN; IN VIVO STUDY; LOSS OF FUNCTION MUTATION; MOLECULAR DYNAMICS; MOLECULAR PATHOLOGY; MOSAICISM; MUTATIONAL ANALYSIS; NONHUMAN; REVIEW; RNA INTERFERENCE; SOMATIC CELL GENETICS; SOMATIC MUTATION; TRANSGENICS; TRANSPOSON; ANIMAL; DISEASES; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; GENOMICS; GROWTH, DEVELOPMENT AND AGING; MOUSE; MUTATION;

MURINAE; RODENTIA;

ANIMALS; DISEASE; DISEASE MODELS, ANIMAL; GENETIC ASSOCIATION STUDIES; GENETIC TESTING; GENOMICS; GROWTH AND DEVELOPMENT; HUMANS; MICE; MUTAGENESIS, INSERTIONAL; MUTAGENS; MUTATION;

EID: 79960945044     PISSN: 15537390     EISSN: 15537404     Source Type: Journal    
DOI: 10.1371/journal.pgen.1002110     Document Type: Review

References (97)

1. Heard E, Tishkoff S, Todd JA, Vidal M, Wagner GP, et al. Ten years of genetics and genomics: what have we achieved and where are we heading? Nat Rev Genet 11: 723-733.
2. Hanahan D, Weinberg RA, Hallmarks of cancer: the next generation. Cell 144: 646-674.
3. Vogelstein B, Kinzler KW, (2004) Cancer genes and the pathways they control. Nat Med 10: 789-799.
4. Choate KA, Lu Y, Zhou J, Choi M, Elias PM, et al. Mitotic Recombination in Patients with Ichthyosis Causes Reversion of Dominant Mutations in KRT10. Science.
5. Rajewsky K, (1996) Clonal selection and learning in the antibody system. Nature 381: 751-758.
6. Muotri AR, Chu VT, Marchetto MC, Deng W, Moran JV, et al. (2005) Somatic mosaicism in neuronal precursor cells mediated by L1 retrotransposition. Nature 435: 903-910.
7. Coufal NG, Garcia-Perez JL, Peng GE, Yeo GW, Mu Y, et al. (2009) L1 retrotransposition in human neural progenitor cells. Nature 460: 1127-1131.
8. Singer T, McConnell MJ, Marchetto MC, Coufal NG, Gage FH, LINE-1 retrotransposons: mediators of somatic variation in neuronal genomes? Trends Neurosci 33: 345-354.
9. Naldini L, Blomer U, Gage FH, Trono D, Verma IM, (1996) Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc Natl Acad Sci U S A 93: 11382-11388.
10. Naldini L, Blomer U, Gallay P, Ory D, Mulligan R, et al. (1996) In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272: 263-267.
11. Miller AD, Miller DG, Garcia JV, Lynch CM, (1993) Use of retroviral vectors for gene transfer and expression. Methods Enzymol 217: 581-599.
12. Tiscornia G, Singer O, Ikawa M, Verma IM, (2003) A general method for gene knockdown in mice by using lentiviral vectors expressing small interfering RNA. Proc Natl Acad Sci U S A 100: 1844-1848.
13. Federspiel MJ, Bates P, Young JA, Varmus HE, Hughes SH, (1994) A system for tissue-specific gene targeting: transgenic mice susceptible to subgroup A avian leukosis virus-based retroviral vectors. Proc Natl Acad Sci U S A 91: 11241-11245.
14. Doetsch F, Caille I, Lim DA, Garcia-Verdugo JM, Alvarez-Buylla A, (1999) Subventricular zone astrocytes are neural stem cells in the adult mammalian brain. Cell 97: 703-716.
15. Murphy GJ, Leavitt AD, (1999) A model for studying megakaryocyte development and biology. Proc Natl Acad Sci U S A 96: 3065-3070.
16. Holland EC, Celestino J, Dai C, Schaefer L, Sawaya RE, et al. (2000) Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice. Nat Genet 25: 55-57.
17. Holland EC, Hively WP, DePinho RA, Varmus HE, (1998) A constitutively active epidermal growth factor receptor cooperates with disruption of G1 cell-cycle arrest pathways to induce glioma-like lesions in mice. Genes Dev 12: 3675-3685.
18. Marumoto T, Tashiro A, Friedmann-Morvinski D, Scadeng M, Soda Y, et al. (2009) Development of a novel mouse glioma model using lentiviral vectors. Nat Med 15: 110-116.
19. Orsulic S, (2002) An RCAS-TVA-based approach to designer mouse models. Mamm Genome 13: 543-547.
20. Kumar M, Keller B, Makalou N, Sutton RE, (2001) Systematic determination of the packaging limit of lentiviral vectors. Hum Gene Ther 12: 1893-1905.
21. Mir LM, Moller PH, Andre F, Gehl J, (2005) Electric pulse-mediated gene delivery to various animal tissues. Adv Genet 54: 83-114.
22. Barnabe-Heider F, Meletis K, Eriksson M, Bergmann O, Sabelstrom H, et al. (2008) Genetic manipulation of adult mouse neurogenic niches by in vivo electroporation. Nat Methods 5: 189-196.
23. Tros de Ilarduya C, Sun Y, Duzgunes N, Gene delivery by lipoplexes and polyplexes. Eur J Pharm Sci 40: 159-170.
24. Keravala A, Calos MP, (2008) Site-specific chromosomal integration mediated by phiC31 integrase. Methods Mol Biol 435: 165-173.
25. Woodard LE, Keravala A, Jung WE, Wapinski OL, Yang Q, et al. Impact of hydrodynamic injection and phiC31 integrase on tumor latency in a mouse model of MYC-induced hepatocellular carcinoma. PLoS ONE 5: e11367 doi:10.1371/journal.pone.0011367.
26. Ding S, Wu X, Li G, Han M, Zhuang Y, et al. (2005) Efficient transposition of the piggyBac (PB) transposon in mammalian cells and mice. Cell 122: 473-483.
27. Ivics Z, Hackett PB, Plasterk RH, Izsvak Z, (1997) Molecular reconstruction of Sleeping Beauty, a Tc1-like transposon from fish, and its transposition in human cells. Cell 91: 501-510.
28. Yant SR, Meuse L, Chiu W, Ivics Z, Izsvak Z, et al. (2000) Somatic integration and long-term transgene expression in normal and haemophilic mice using a DNA transposon system. Nat Genet 25: 35-41.
29. Cadinanos J, Bradley A, (2007) Generation of an inducible and optimized piggyBac transposon system. Nucleic Acids Res 35: e87.
30. Luo G, Ivics Z, Izsvak Z, Bradley A, (1998) Chromosomal transposition of a Tc1/mariner-like element in mouse embryonic stem cells. Proc Natl Acad Sci U S A 95: 10769-10773.
31. Wang W, Lin C, Lu D, Ning Z, Cox T, et al. (2008) Chromosomal transposition of PiggyBac in mouse embryonic stem cells. Proc Natl Acad Sci U S A 105: 9290-9295.
32. Dupuy AJ, Clark K, Carlson CM, Fritz S, Davidson AE, et al. (2002) Mammalian germ-line transgenesis by transposition. Proc Natl Acad Sci U S A 99: 4495-4499.
33. Wiesner SM, Decker SA, Larson JD, Ericson K, Forster C, et al. (2009) De novo induction of genetically engineered brain tumors in mice using plasmid DNA. Cancer Res 69: 431-439.
34. Bell JB, Podetz-Pedersen KM, Aronovich EL, Belur LR, McIvor RS, et al. (2007) Preferential delivery of the Sleeping Beauty transposon system to livers of mice by hydrodynamic injection. Nat Protoc 2: 3153-3165.
35. Saridey SK, Liu L, Doherty JE, Kaja A, Galvan DL, et al. (2009) PiggyBac transposon-based inducible gene expression in vivo after somatic cell gene transfer. Mol Ther 17: 2115-2120.
36. Nakanishi H, Higuchi Y, Kawakami S, Yamashita F, Hashida M, piggyBac transposon-mediated long-term gene expression in mice. Mol Ther 18: 707-714.
37. Yusa K, Rad R, Takeda J, Bradley A, (2009) Generation of transgene-free induced pluripotent mouse stem cells by the piggyBac transposon. Nat Methods 6: 363-369.
38. Kahlig KM, Saridey SK, Kaja A, Daniels MA, George AL Jr, et al. Multiplexed transposon-mediated stable gene transfer in human cells. Proc Natl Acad Sci U S A 107: 1343-1348.
39. Nakazawa Y, Huye LE, Dotti G, Foster AE, Vera JF, et al. (2009) Optimization of the PiggyBac transposon system for the sustained genetic modification of human T lymphocytes. J Immunother 32: 826-836.
40. Beroukhim R, Mermel CH, Porter D, Wei G, Raychaudhuri S, et al. The landscape of somatic copy-number alteration across human cancers. Nature 463: 899-905.
41. Jones S, Chen WD, Parmigiani G, Diehl F, Beerenwinkel N, et al. (2008) Comparative lesion sequencing provides insights into tumor evolution. Proc Natl Acad Sci U S A 105: 4283-4288.
42. Jones S, Zhang X, Parsons DW, Lin JC, Leary RJ, et al. (2008) Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science 321: 1801-1806.
43. Leary RJ, Lin JC, Cummins J, Boca S, Wood LD, et al. (2008) Integrated analysis of homozygous deletions, focal amplifications, and sequence alterations in breast and colorectal cancers. Proc Natl Acad Sci U S A 105: 16224-16229.
44. Parsons DW, Jones S, Zhang X, Lin JC, Leary RJ, et al. (2008) An integrated genomic analysis of human glioblastoma multiforme. Science 321: 1807-1812.
45. Sjoblom T, Jones S, Wood LD, Parsons DW, Lin J, et al. (2006) The consensus coding sequences of human breast and colorectal cancers. Science 314: 268-274.
46. Wood LD, Parsons DW, Jones S, Lin J, Sjoblom T, et al. (2007) The genomic landscapes of human breast and colorectal cancers. Science 318: 1108-1113.
47. Meyerson M, Gabriel S, Getz G, Advances in understanding cancer genomes through second-generation sequencing. Nat Rev Genet 11: 685-696.
48. Sharpless NE, Depinho RA, (2006) The mighty mouse: genetically engineered mouse models in cancer drug development. Nat Rev Drug Discov 5: 741-754.
49. Fiebig HH, Berger DP, Winterhalter BR, Plowman J, (1990) In vitro and in vivo evaluation of US-NCI compounds in human tumor xenografts. Cancer Treat Rev 17: 109-117.
50. Johnson JI, Decker S, Zaharevitz D, Rubinstein LV, Venditti JM, et al. (2001) Relationships between drug activity in NCI preclinical in vitro and in vivo models and early clinical trials. Br J Cancer 84: 1424-1431.
51. Brehm MA, Shultz LD, Greiner DL, Humanized mouse models to study human diseases. Curr Opin Endocrinol Diabetes Obes 17: 120-125.
52. Legrand N, Ploss A, Balling R, Becker PD, Borsotti C, et al. (2009) Humanized mice for modeling human infectious disease: challenges, progress, and outlook. Cell Host Microbe 6: 5-9.
53. Shultz LD, Ishikawa F, Greiner DL, (2007) Humanized mice in translational biomedical research. Nat Rev Immunol 7: 118-130.
54. Takahashi K, Yamanaka S, (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126: 663-676.
55. Hanna J, Wernig M, Markoulaki S, Sun CW, Meissner A, et al. (2007) Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science 318: 1920-1923.
56. Tsuji O, Miura K, Okada Y, Fujiyoshi K, Mukaino M, et al. Therapeutic potential of appropriately evaluated safe-induced pluripotent stem cells for spinal cord injury. Proc Natl Acad Sci U S A 107: 12704-12709.
57. Xu D, Alipio Z, Fink LM, Adcock DM, Yang J, et al. (2009) Phenotypic correction of murine hemophilia A using an iPS cell-based therapy. Proc Natl Acad Sci U S A 106: 808-813.
58. Alipio Z, Liao W, Roemer EJ, Waner M, Fink LM, et al. Reversal of hyperglycemia in diabetic mouse models using induced-pluripotent stem (iPS)-derived pancreatic beta-like cells. Proc Natl Acad Sci U S A 107: 13426-13431.
59. Wernig M, Zhao JP, Pruszak J, Hedlund E, Fu D, et al. (2008) Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease. Proc Natl Acad Sci U S A 105: 5856-5861.
60. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, et al. (2007) Induced pluripotent stem cell lines derived from human somatic cells. Science 318: 1917-1920.
61. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, et al. (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131: 861-872.
62. Park IH, Arora N, Huo H, Maherali N, Ahfeldt T, et al. (2008) Disease-specific induced pluripotent stem cells. Cell 134: 877-886.
63. Bric A, Miething C, Bialucha CU, Scuoppo C, Zender L, et al. (2009) Functional identification of tumor-suppressor genes through an in vivo RNA interference screen in a mouse lymphoma model. Cancer Cell 16: 324-335.
64. Meacham CE, Ho EE, Dubrovsky E, Gertler FB, Hemann MT, (2009) In vivo RNAi screening identifies regulators of actin dynamics as key determinants of lymphoma progression. Nat Genet 41: 1133-1137.
65. Zender L, Xue W, Zuber J, Semighini CP, Krasnitz A, et al. (2008) An oncogenomics-based in vivo RNAi screen identifies tumor suppressors in liver cancer. Cell 135: 852-864.
66. Jonkers J, Berns A, (1996) Retroviral insertional mutagenesis as a strategy to identify cancer genes. Biochim Biophys Acta 1287: 29-57.
67. Uren AG, Kool J, Berns A, van Lohuizen M, (2005) Retroviral insertional mutagenesis: past, present and future. Oncogene 24: 7656-7672.
68. Kool J, Berns A, (2009) High-throughput insertional mutagenesis screens in mice to identify oncogenic networks. Nat Rev Cancer 9: 389-399.
69. Mikkers H, Berns A, (2003) Retroviral insertional mutagenesis: tagging cancer pathways. Adv Cancer Res 88: 53-99.
70. Cooley L, Kelley R, Spradling A, (1988) Insertional mutagenesis of the Drosophila genome with single P elements. Science 239: 1121-1128.
71. Kleckner N, Roth J, Botstein D, (1977) Genetic engineering in vivo using translocatable drug-resistance elements. New methods in bacterial genetics. J Mol Biol 116: 125-159.
72. Wu S, Ying G, Wu Q, Capecchi MR, (2007) Toward simpler and faster genome-wide mutagenesis in mice. Nat Genet 39: 922-930.
73. Dupuy AJ, Fritz S, Largaespada DA, (2001) Transposition and gene disruption in the male germline of the mouse. Genesis 30: 82-88.
74. Fischer SE, Wienholds E, Plasterk RH, (2001) Regulated transposition of a fish transposon in the mouse germ line. Proc Natl Acad Sci U S A 98: 6759-6764.
75. Horie K, Kuroiwa A, Ikawa M, Okabe M, Kondoh G, et al. (2001) Efficient chromosomal transposition of a Tc1/mariner- like transposon Sleeping Beauty in mice. Proc Natl Acad Sci U S A 98: 9191-9196.
76. Nguyen D, Xu T, (2008) The expanding role of mouse genetics for understanding human biology and disease. Dis Model Mech 1: 56-66.
77. Wang W, Bradley A, Huang Y, (2009) A piggyBac transposon-based genome-wide library of insertionally mutated Blm-deficient murine ES cells. Genome Res 19: 667-673.
78. Bender AM, Collier LS, Rodriguez FJ, Tieu C, Larson JD, et al. Sleeping beauty-mediated somatic mutagenesis implicates CSF1 in the formation of high-grade astrocytomas. Cancer Res 70: 3557-3565.
79. Collier LS, Adams DJ, Hackett CS, Bendzick LE, Akagi K, et al. (2009) Whole-body sleeping beauty mutagenesis can cause penetrant leukemia/lymphoma and rare high-grade glioma without associated embryonic lethality. Cancer Res 69: 8429-8437.
80. Collier LS, Carlson CM, Ravimohan S, Dupuy AJ, Largaespada DA, (2005) Cancer gene discovery in solid tumours using transposon-based somatic mutagenesis in the mouse. Nature 436: 272-276.
81. Dupuy AJ, Akagi K, Largaespada DA, Copeland NG, Jenkins NA, (2005) Mammalian mutagenesis using a highly mobile somatic Sleeping Beauty transposon system. Nature 436: 221-226.
82. Dupuy AJ, Rogers LM, Kim J, Nannapaneni K, Starr TK, et al. (2009) A modified sleeping beauty transposon system that can be used to model a wide variety of human cancers in mice. Cancer Res 69: 8150-8156.
83. Rad R, Rad L, Wang W, Cadinanos J, Vassiliou G, et al. PiggyBac Transposon Mutagenesis: A Tool for Cancer Gene Discovery in Mice. Science.
84. Keng VW, Villanueva A, Chiang DY, Dupuy AJ, Ryan BJ, et al. (2009) A conditional transposon-based insertional mutagenesis screen for genes associated with mouse hepatocellular carcinoma. Nat Biotechnol 27: 264-274.
85. Starr TK, Allaei R, Silverstein KA, Staggs RA, Sarver AL, et al. (2009) A transposon-based genetic screen in mice identifies genes altered in colorectal cancer. Science 323: 1747-1750.
86. Vassiliou GS, Cooper JL, Rad R, Li J, Rice S, et al. Mutant nucleophosmin and cooperating pathways drive leukemia initiation and progression in mice. Nat Genet.
87. Liang Q, Kong J, Stalker J, Bradley A, (2009) Chromosomal mobilization and reintegration of Sleeping Beauty and PiggyBac transposons. Genesis 47: 404-408.
88. Huang X, Guo H, Tammana S, Jung YC, Mellgren E, et al. Gene Transfer Efficiency and Genome-Wide Integration Profiling of Sleeping Beauty, Tol2, and PiggyBac Transposons in Human Primary T Cells. Mol Ther.
89. Elick TA, Bauser CA, Fraser MJ, (1996) Excision of the piggyBac transposable element in vitro is a precise event that is enhanced by the expression of its encoded transposase. Genetica 98: 33-41.
90. Liu G, Aronovich EL, Cui Z, Whitley CB, Hackett PB, (2004) Excision of Sleeping Beauty transposons: parameters and applications to gene therapy. J Gene Med 6: 574-583.
91. Keng VW, Yae K, Hayakawa T, Mizuno S, Uno Y, et al. (2005) Region-specific saturation germline mutagenesis in mice using the Sleeping Beauty transposon system. Nat Methods 2: 763-769.
92. Geurts AM, Collier LS, Geurts JL, Oseth LL, Bell ML, et al. (2006) Gene mutations and genomic rearrangements in the mouse as a result of transposon mobilization from chromosomal concatemers. PLoS Genet 2: e156 doi:10.1371/journal.pgen.0020156.
93. Lee T, Luo L, (2001) Mosaic analysis with a repressible cell marker (MARCM) for Drosophila neural development. Trends Neurosci 24: 251-254.
94. Pagliarini RA, Xu T, (2003) A genetic screen in Drosophila for metastatic behavior. Science 302: 1227-1231.
95. Xu T, Rubin GM, (1993) Analysis of genetic mosaics in developing and adult Drosophila tissues. Development 117: 1223-1237.
96. White RM, Sessa A, Burke C, Bowman T, LeBlanc J, et al. (2008) Transparent adult zebrafish as a tool for in vivo transplantation analysis. Cell Stem Cell 2: 183-189.
97. Zong H, Espinosa JS, Su HH, Muzumdar MD, Luo L, (2005) Mosaic analysis with double markers in mice. Cell 121: 479-492.